SUN 1165 demonstrates selective inhibition of cardiac sodium channels in preclinical models, suggesting potential efficacy as an antiarrhythmic agent for both ventricular and supraventricular tachyarrhythmias.
No takes yet. Share an insight, caveat, or question.
Merits testing in intact arrhythmia models; leaves open translation to human antiarrhythmic use.
Hattori et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: